Construction and Application of Database of Hebei Provincial Gastric Cancer Collaborative Network Driven by Artificial Intelligence Technology
Launched by QUN ZHAO · Jul 12, 2024
Trial Information
Current as of November 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the treatment and management of gastric cancer in Hebei Province by creating a database that uses artificial intelligence (AI) technology. The goal is to gather and analyze information from various hospitals and research centers, including patient medical data and treatment results. By doing this, researchers hope to identify new indicators of the disease and find better treatment options, ultimately leading to improved outcomes for patients with gastric cancer.
If you or a loved one has gastric cancer, you may be eligible to participate in this study, as there are no specific exclusions based on age or gender. Participants can expect to contribute to a larger effort that promotes better understanding and management of gastric cancer, while also benefiting from the real-time sharing of information among healthcare providers and researchers. This collaboration aims to enhance the overall care for patients facing this condition in the region.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients with gastric cancer
- Exclusion Criteria:
- • None
About Qun Zhao
Qun Zhao is a dedicated clinical trial sponsor with a robust commitment to advancing medical research and improving patient outcomes. With expertise in designing and implementing innovative clinical studies, Qun Zhao focuses on developing new therapies and interventions across various therapeutic areas. The organization prioritizes ethical standards, rigorous scientific methodologies, and collaboration with healthcare professionals and regulatory bodies to ensure the integrity and success of its trials. Through a patient-centered approach, Qun Zhao aims to contribute significantly to the evolving landscape of healthcare and drive transformative solutions for unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shijiazhuang, Hebei, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported